Why does weight come back after I lose it?

Weight regain is the expected biological response to weight loss, not evidence of a character problem. A body that has lost a substantial amount of weight behaves as though it is under threat, and it defends the weight it has lost with mechanisms you do not consciously control.

What changes in the body after weight loss

Two things happen together. Appetite-regulating hormones shift in the direction of hunger, and they stay shifted. In a study published in the New England Journal of Medicine in 2011, participants who lost weight over ten weeks still had altered levels of appetite hormones, including lower leptin and higher ghrelin, along with greater subjective hunger, a full year later. Separately, resting energy expenditure falls by more than the loss of tissue alone would predict, so the smaller body burns less than an equivalent body that was never larger. Neither of those is a decision.

What the medication trials demonstrate

Withdrawal trials make the point without any confounding from motivation, because participants had already succeeded. In the STEP 1 extension, people who lost 17.3 percent of their body weight on semaglutide regained 11.6 percentage points in the year after stopping, ending 5.6 percent below where they started, with cardiometabolic improvements reverting towards baseline. In SURMOUNT-4, among those switched from tirzepatide to placebo, 82 percent regained more than a quarter of the weight lost, and blood pressure, waist circumference, non-HDL cholesterol and HbA1c all worsened in proportion to how much returned.

What this changes about how obesity is treated

If regain is driven by biology, then treating obesity as a short course of anything is a design error. The 2026 ADA standards advise continuing obesity medications after treatment goals are reached, because discontinuation often results in weight recurrence and worsening of cardiometabolic risk factors. The Lancet Commission on clinical obesity, published in January 2025, frames obesity as a chronic condition with organ-level consequences rather than as a lifestyle outcome. Both statements point in the same direction: plan for maintenance from the beginning.

The practical consequence is that the maintenance phase needs as much design as the loss phase. Decide in advance what your monitoring will be, what threshold triggers a review, and whether the plan involves continuing medication, a lower dose, or a supervised trial off treatment. Regain is much easier to interrupt early than to reverse late.